Skip to main content
Log in

Comparison of neutrophil–lymphocyte ratio (NLR) in Parkinson’s disease subtypes

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

It has been hypothesized that chronic inflammation may play an important role in the development and progression of the neurodegeneration of Idiopathic Parkinson’s disease (IPD). Neutrophil–lymphocyte ratio (NLR) is a marker that indicates the peripheral inflammation. There is only one study regarding NLR and IPD. In this study, we assessed to investigate NLR in patients with IPD, comparing the results with controls and to determine whether there is a difference in NLR levels in subgroups of IPD (akinetic-rigid and tremor-dominant) differ in their levels of NLR. Medical records of 200 IPD patients and 60 controls reviewed retrospectively. Forty-six IPD patients met the inclusion criteria. NLR was calculated by dividing neutrophil count to lymphocyte count. Thirteen akinetic-rigid (AR-IPD) and thirty-three tremor-dominant (TD-IPD) patients’ and controls results were compared. There was not a statistically difference between the NLR levels of IPD patients, controls, and AR-IPD and TD-IPD patients. This result suggests that cerebral inflammation is in the forefront in the development of neurodegeneration in IPD, and that more evidence is needed for the role of peripheral inflammation in the development progression of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Akıl E, Bulut A, Kaplan İ, Özdemir HH, Arslan D, Aluçlu MU (2015) The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease. Neurol Sci 36:423–428

    Article  PubMed  Google Scholar 

  2. Alberio T, Pippione AC, Comi C, Olgiati S, Cecconi D, Zibetti M, Lopiano L, Fasano M (2012) Dopaminergic therapies modulate the T-cell proteome of patients with Parkinson’s disease. IUBMB Life 64:846–852

    Article  CAS  PubMed  Google Scholar 

  3. Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, Zein NN, Feldstein AE (2012) Neutrophil to lymphotocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int 2:297–302

    Article  Google Scholar 

  4. Baba Y, Kuroiwa A, Uitti RJ, Wszolek KZ (2005) Yamada T. Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord 11:493–498

    Article  PubMed  Google Scholar 

  5. Dobbs RJ, Charlet A, Purkiss AG, Dobbs SM, Weller C, Peterson DW (1999) Association of circulating TNF-α and IL-6 with ageing and parkinsonism. Acta Neurol Scad. 100:4–31

    Google Scholar 

  6. Dufek M, Hamanova M, Lokaj J, Goldemund D, Rektorava I, Michalklova Z, Sheardova K, Rektor IM (2009) Serum inflamatory biomarkers in Parkinson’s disease. Parkinsonism Relat Disord 5:318–320

    Article  Google Scholar 

  7. Ferrari CC, Tarelli R (2011) Parkinson’s disease and systemic inflamation. Parkinson’s Dis. doi:10.4061/2011/436813

    Google Scholar 

  8. Hisanaga K, Asagi M, Itoyama Y, Iwasaki Y (2001) Increase in peripheral CD bright +CD8 dull T cells in Parkinson disease. Arc Neurol. 58:1580–1583

    Article  CAS  Google Scholar 

  9. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study. J Neurol Neurosurg Psychiatry 55:181–184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Jung MR, Park YK, Jeong O, Sean JW et al (2012) Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol 104:504–510

    Article  Google Scholar 

  11. Kustrimovic N, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Comi C, Mauri M, Minafra B, Riboldazzi G, Sanchez-Guajardo V, Marino F, Cosentino M (2016) Dopaminergic receptors on CD4+ T naive and memory lymphocytes correlate with motor impairment in patients with Parkinson’s disease. Sci Rep 6:33738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Long-Smith CM, Sullivan AM, Nolan YM (2009) The influence of microglia on the pathogenesis of Parkinson’s disease. Prog Neurobiol 89:277–287

    Article  CAS  PubMed  Google Scholar 

  13. McGeer PL, McGeer EG (2004) İnflammation and neurodegeneration in Parkinson’s disease. Parkinsonism Relat Disord 10:3–7

    Article  Google Scholar 

  14. McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24:574–576

    Article  CAS  PubMed  Google Scholar 

  15. McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s Disease brains. Neurology 38:1285–1291

    Article  CAS  PubMed  Google Scholar 

  16. Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease (2003) The unified Parkinson’s disease rating scale (UPDRS): status and recommendations. Mov Disord 18:738–750

    Article  Google Scholar 

  17. Pacheco R, Prado CE, Barrientos MJ, Bernales S (2009) Role of dopamin in the physiology of T-cells and dendritic cells. J Neuroimmunol 216:8–19

    Article  CAS  PubMed  Google Scholar 

  18. Phani S, Loike JD, Przedborski S (2012) Neurodegeneration and Inflammation in Parkinson’s disease. Parkinsonism Relat Disord 1851:207–209

    Article  Google Scholar 

  19. Przedborski S (2007) Neuroinflamation and Parkinson’s disease. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. Elsevier, Amsterdam, pp 535–551

    Google Scholar 

  20. Rembach A, Wilson B, Ellis K, Amos D, Rowe C et al (2013) Neutrophil-lymphocyte ratio in Alzheimer’s disease: data from Australian Imaging Biomarker and Lifestyle study of ageing. Alzheimers & Dementia 9:203

    Article  Google Scholar 

  21. Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S (2010) The immunoregulatory role of dopamine: an update. Brain Behav Immun 24:525–528

    Article  CAS  PubMed  Google Scholar 

  22. Scalzo P, Kummer A, Cardoso F, Teixeira AL (2009) Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson’s disease. Journal Neuroimmunol. 216:122–125

    Article  CAS  Google Scholar 

  23. Yamada T, McGeer PL, McGeer EG (1991) Relationship of complement-activated oligodendrocytes to reactive microglia and neuronal pathology in neurodegenerative disease. Dementia 2:71–77

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ceyla Ataç Uçar.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ataç Uçar, C., Gökçe Çokal, B., Ünal Artık, H.A. et al. Comparison of neutrophil–lymphocyte ratio (NLR) in Parkinson’s disease subtypes. Neurol Sci 38, 287–293 (2017). https://doi.org/10.1007/s10072-016-2758-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2758-8

Keywords

Navigation